AJJ Healthcare Management, a wholly-owned subsidiary of AJJ Medtech (SGX:584), has signed a supplemental agreement with China's Hangzhou Huaxi Intelligent Technology to advance the development and commercialization of its HIT-X2 humanoid eldercare robot for home use.
The company said the Class A medical device product notification for HIT-X2 was completed with Singapore's Health Sciences Authority on Oct. 20, with AJJ Healthcare listed as the product owner and notifying entity.
AJJ Healthcare will oversee localization, market development and sales in Singapore, while Huaxi Intelligent will lead product and technology development.
AJJ Medtech plans technology demonstrations and promotional activities ahead of a formal launch, with pre-order timelines and pricing to be announced separately.
